MML Investors Services
VRCA icon

MML Investors Services’s Verrica Pharmaceuticals VRCA Stock Holding History

MML Investors Services’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,731
Closed -$162K – 2585
2024
Q1 		$162K Sell
2,731
-12,024
-81% -$664K ﹤0.01% 2378
2023
Q4 		$1.08M Sell
14,755
-1,600
-10% -$65.7K 0.01% 1307
2023
Q3 		$635K Buy
16,355
+2,200
+16% +$112K ﹤0.01% 1492
2023
Q2 		$817K Buy
14,155
+2,620
+23% +$159K ﹤0.01% 1335
2023
Q1 		$750K Buy
11,535
+1,600
+16% +$96.8K 0.01% 1212
2022
Q4 		$273K Buy
9,935
+940
+10% +$25.1K ﹤0.01% 1840
2022
Q3 		$263K Buy
8,995
+4,605
+105% +$158K ﹤0.01% 1766
2022
Q2 		$84K Sell
4,390
-1,660
-27% -$83.4K ﹤0.01% 1983
2022
Q1 		$491K Buy
6,050
+962
+19% +$79.3K ﹤0.01% 1465
2021
Q4 		$466K Buy
5,088
+600
+13% +$68K ﹤0.01% 1456
2021
Q3 		$561K Buy
4,488
+1,040
+30% +$117K ﹤0.01% 1282
2021
Q2 		$390K Buy
3,448
+1,340
+64% +$162K ﹤0.01% 1467
2021
Q1 		$319K Sell
2,108
-550
-21% -$76.1K ﹤0.01% 1483
2020
Q4 		$306K Buy
2,658
+1,508
+131% +$139K ﹤0.01% 1381
2020
Q3 		$89K Buy
+1,150
New +$94.2K ﹤0.01% 1543

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

MML Investors Services's VRCA Position: Q2 2024 in Review

MML Investors Services sold out of Verrica Pharmaceuticals (VRCA) in Q2 2024, closing a stake of 2,731 shares — an estimated $162K sold.

MML Investors Services first reported a position in VRCA in Q3 2020 and held it in 15 quarters. The position peaked at $1.08M in Q4 2023. 74 funds tracked by Wall St. Rank hold VRCA as of Q2 2024.

  • MML Investors Services reported no remaining Verrica Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • MML Investors Services sold 2,731 Verrica Pharmaceuticals shares in Q2 2024, an estimated $162K.
  • MML Investors Services first reported a position in Verrica Pharmaceuticals in Q3 2020 and held it in 15 quarters.
  • MML Investors Services's Verrica Pharmaceuticals position peaked at $1.08M in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2024.

Based on MML Investors Services's 13F filing for Q2 2024, filed 14 Aug 2024.